DK1641438T3 - Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel - Google Patents
Fremgangsmåde til fremstilling af den amorfe form af et lægemiddelInfo
- Publication number
- DK1641438T3 DK1641438T3 DK05758626.5T DK05758626T DK1641438T3 DK 1641438 T3 DK1641438 T3 DK 1641438T3 DK 05758626 T DK05758626 T DK 05758626T DK 1641438 T3 DK1641438 T3 DK 1641438T3
- Authority
- DK
- Denmark
- Prior art keywords
- amorphous form
- drug
- preparing
- preparation
- active pharmaceutical
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B11/00—Machines or apparatus for drying solid materials or objects with movement which is non-progressive
- F26B11/12—Machines or apparatus for drying solid materials or objects with movement which is non-progressive in stationary drums or other mainly-closed receptacles with moving stirring devices
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/041—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum for drying flowable materials, e.g. suspensions, bulk goods, in a continuous operation, e.g. with locks or other air tight arrangements for charging/discharging
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57621604P | 2004-06-01 | 2004-06-01 | |
| US58377804P | 2004-06-28 | 2004-06-28 | |
| US59970004P | 2004-08-05 | 2004-08-05 | |
| PCT/US2005/019485 WO2005117837A1 (en) | 2004-06-01 | 2005-06-01 | Process for preparation of amorphous form of a drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1641438T3 true DK1641438T3 (da) | 2010-06-07 |
Family
ID=35134738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05758626.5T DK1641438T3 (da) | 2004-06-01 | 2005-06-01 | Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7589128B2 (da) |
| JP (1) | JP2008500405A (da) |
| KR (1) | KR20060123772A (da) |
| AT (1) | ATE458476T1 (da) |
| CA (1) | CA2560984A1 (da) |
| DE (1) | DE602005019509D1 (da) |
| DK (1) | DK1641438T3 (da) |
| ES (1) | ES2339682T3 (da) |
| IL (1) | IL179719A0 (da) |
| MX (1) | MXPA06010084A (da) |
| WO (1) | WO2005117837A1 (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060083784A1 (en) * | 2002-08-07 | 2006-04-20 | Smithkline Beecham Corporation | Amorphous pharmaceutical compositions |
| KR20080112424A (ko) | 2004-10-15 | 2008-12-24 | 테바 파마슈티컬 인더스트리즈 리미티드 | 텔미사르탄의 제조 방법 |
| MX2007005348A (es) * | 2004-11-03 | 2007-06-25 | Teva Pharma | Formas amorfas y polimorficas de sodio de telmisartan. |
| MX2007005222A (es) | 2004-12-01 | 2007-06-26 | Teva Gyogyszergyar Zartkoruen | Pimecrolimus amorfo no higroscopico y en polvo. |
| WO2006079921A2 (en) | 2005-01-28 | 2006-08-03 | Pfizer Products Inc. | Drying of drug-containing particles |
| KR20090015186A (ko) | 2005-07-05 | 2009-02-11 | 테바 파마슈티컬 인더스트리즈 리미티드 | 몬테루카스트의 정제 |
| WO2007059325A2 (en) * | 2005-11-16 | 2007-05-24 | Teva Pharmaceutical Industries Ltd. | Drying methods of montelukast sodium by azeotropic removal of the solvent |
| GB0613925D0 (en) | 2006-07-13 | 2006-08-23 | Unilever Plc | Improvements relating to nanodispersions |
| WO2008012617A1 (en) | 2006-07-21 | 2008-01-31 | Pfizer Products Inc. | Drying of drug-containing particles |
| GB2441328A (en) * | 2006-08-30 | 2008-03-05 | Alpharma Aps | A method for obtaining mupirocin calcium |
| US20080187684A1 (en) * | 2007-02-07 | 2008-08-07 | Imra America, Inc. | Method for depositing crystalline titania nanoparticles and films |
| US20090234125A1 (en) * | 2007-11-26 | 2009-09-17 | Eli Lancry | Amorphous retapamulin and processes for preparation thereof |
| GB2457452B (en) * | 2008-02-12 | 2010-05-12 | Pliva Lachema As | Amorphous form of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) amminedichloroplatinum (IV) |
| EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
| WO2011121596A2 (en) * | 2010-04-01 | 2011-10-06 | Neuland Laboratories Ltd. | Crystal modification of moxifloxacin hydrochloride |
| US8471030B2 (en) | 2010-12-06 | 2013-06-25 | Orochem Technologies Inc. | Purification of montelukast using simulated moving bed |
| WO2020049505A1 (en) | 2018-09-06 | 2020-03-12 | Innopharmascreen Inc. | Methods and compositions for treatment of asthma or parkinson's disease |
| WO2025146702A1 (en) * | 2024-01-03 | 2025-07-10 | Msn Laboratories Private Limited, R&D Center | Solid state forms of 1-{(2s,5r)-2-methyl-5-[(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino] piperidine-1-yl}prop-2-en-1-one 4-methylbenzene-1-sulfonic acid |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643240A1 (de) | 1966-09-16 | 1971-06-24 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane |
| US4071536A (en) | 1971-06-12 | 1978-01-31 | Beecham Group Limited | Antibiotics |
| GB1395907A (en) | 1971-06-12 | 1975-05-29 | Beecham Group Ltd | Antibiotics |
| US3977943A (en) | 1971-06-12 | 1976-08-31 | Beecham Group Limited | Antibiotics |
| JPS5270083A (en) | 1975-12-04 | 1977-06-10 | Yoshitomi Pharmaceut Ind Ltd | Manufacture of an antibiotics, trans-pseudomonic acid |
| GB1577730A (en) | 1976-10-23 | 1980-10-29 | Beecham Group Ltd | Treatment of infections with pseudomonicacid salts or esters thereof |
| GB1577545A (en) | 1977-07-27 | 1980-10-22 | Beecham Group Ltd | Treatment of swine dysenter |
| CA1103264A (en) | 1977-09-30 | 1981-06-16 | Norman H. Rogers | Purification of pseudomonic acid |
| CA1115699A (en) | 1978-05-20 | 1982-01-05 | Alan D. Curzons | Lithium pseudomonate and its preparation |
| CA1196284A (en) | 1982-05-28 | 1985-11-05 | Joshua Oduro-Yeboah | Pharmaceutical formulations |
| GB8415579D0 (en) | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
| GB8428952D0 (en) | 1984-11-16 | 1984-12-27 | Beecham Group Plc | Formulations |
| GB8530796D0 (en) | 1985-12-13 | 1986-01-22 | Beecham Group Plc | Pharmaceutical composition |
| IE59628B1 (en) | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
| US5594026A (en) | 1990-12-11 | 1997-01-14 | Smithkline Beecham Group P.L.C. | Polymorphs of crystalline mupirocin |
| US5292892A (en) | 1991-05-07 | 1994-03-08 | Sankyo Company, Limited | Anti-bacterial compound and pharmaceutical compositions thereof |
| US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| IL129237A0 (en) | 1996-10-01 | 2000-02-17 | Smithkline Beecham Corp | Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
| AU5459698A (en) * | 1997-11-26 | 1999-06-15 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| US6231875B1 (en) | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| US6306345B1 (en) | 1998-05-06 | 2001-10-23 | Universal Preservation Technologies, Inc. | Industrial scale barrier technology for preservation of sensitive biological materials at ambient temperatures |
| PL358615A1 (en) | 1999-02-03 | 2004-08-09 | Biogal Gyogyszergyar Rt | Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| AU771214B2 (en) | 1999-02-03 | 2004-03-18 | Teva Gyogyszergyar Reszvenytarsasag | Process for the isolation of pseudomonic acid a from pseudomonic acid complex-containing culture broth |
| IN191492B (da) | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
| US6335023B1 (en) | 1999-06-30 | 2002-01-01 | Ruey J. Yu | Oligosaccharide aldonic acids and their topical use |
| US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
| IL137363A (en) | 2000-07-18 | 2005-12-18 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| CZ200467A3 (cs) | 2001-06-21 | 2004-10-13 | Biogalágyogyszergyarárt | Metabolicky řízený způsob fermentace pro výrobu pseudomonové kyseliny |
| ATE440938T1 (de) | 2001-07-11 | 2009-09-15 | Procter & Gamble | Verfahren zur oberflächenreinigung mittels eines dispergierten polymers |
| EP1455769A4 (en) | 2001-12-28 | 2004-09-22 | Biogal Gyogyszergyar | METHOD FOR PRODUCING CRYSTALLINE AND AMORPHIC MUPIROCIN CALCIUM |
| PT1469833T (pt) | 2002-02-01 | 2021-07-13 | Bend Res Inc | Método para produzir dispersões de fármaco amorfo sólido seco por pulverização homogéneas utilizando aparelho de secagem por pulverização modificado |
| EP1469830A2 (en) | 2002-02-01 | 2004-10-27 | Pfizer Products Inc. | Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles |
| IL150907A (en) | 2002-07-25 | 2007-07-04 | Stephan Cherkez | Process for the preparation of stable amorphous calcium pseudomonate |
| MX2007005222A (es) | 2004-12-01 | 2007-06-26 | Teva Gyogyszergyar Zartkoruen | Pimecrolimus amorfo no higroscopico y en polvo. |
-
2005
- 2005-06-01 DE DE602005019509T patent/DE602005019509D1/de not_active Expired - Lifetime
- 2005-06-01 JP JP2007527596A patent/JP2008500405A/ja active Pending
- 2005-06-01 DK DK05758626.5T patent/DK1641438T3/da active
- 2005-06-01 US US11/143,312 patent/US7589128B2/en not_active Expired - Fee Related
- 2005-06-01 AT AT05758626T patent/ATE458476T1/de not_active IP Right Cessation
- 2005-06-01 WO PCT/US2005/019485 patent/WO2005117837A1/en not_active Ceased
- 2005-06-01 KR KR1020067018664A patent/KR20060123772A/ko not_active Ceased
- 2005-06-01 ES ES05758626T patent/ES2339682T3/es not_active Expired - Lifetime
- 2005-06-01 MX MXPA06010084A patent/MXPA06010084A/es unknown
- 2005-06-01 CA CA002560984A patent/CA2560984A1/en not_active Abandoned
-
2006
- 2006-11-30 IL IL179719A patent/IL179719A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL179719A0 (en) | 2007-05-15 |
| MXPA06010084A (es) | 2007-03-01 |
| ES2339682T3 (es) | 2010-05-24 |
| WO2005117837A1 (en) | 2005-12-15 |
| US7589128B2 (en) | 2009-09-15 |
| CA2560984A1 (en) | 2005-12-15 |
| DE602005019509D1 (de) | 2010-04-08 |
| KR20060123772A (ko) | 2006-12-04 |
| US20050272768A1 (en) | 2005-12-08 |
| JP2008500405A (ja) | 2008-01-10 |
| ATE458476T1 (de) | 2010-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1641438T3 (da) | Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel | |
| FI7617U1 (fi) | Amorfisen aktiivisen ainesosan stabiloitu farmaseuttinen valmiste | |
| EA201200937A1 (ru) | Твердая лекарственная форма тикагрелора | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
| CY1113462T1 (el) | Μορφη δοσολογιας περιεχουσα παντοπραζολη ως δραστικο συστατικο | |
| NO20074295L (no) | Substituerte gamma lactamer som terapeutiske midler | |
| BRPI0514738A (pt) | derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos | |
| EA200970532A1 (ru) | Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола | |
| WO2005089718A3 (en) | Pharmaceutical compositions | |
| SE0401342D0 (sv) | Therapeutic compounds | |
| DE602005007339D1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| EA201201202A1 (ru) | Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана | |
| DK1511489T3 (da) | Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A | |
| NO20071798L (no) | Dermalt pafore formuleringer for behandling av hudsykdommer i dyr | |
| NO20071806L (no) | Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel. | |
| MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
| SE0401655D0 (sv) | New compounds | |
| EA200870223A1 (ru) | Производные бензоизоиндола для лечения боли | |
| IL195062A0 (en) | Process for the preparation of solid sterile active pharmaceutical ingredient | |
| EA200602154A1 (ru) | Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5 | |
| DK1617827T3 (da) | Farmaceutisk sammensætning i form af en hydrogel til den transdermale administration af aktivstoffer | |
| AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
| TR200601092T1 (tr) | İrbesartan etkin maddesi içeren yeni oral farmasötik formülasyonlar. | |
| IS7383A (is) | Skammtaform með stýrða lyflosun til inngjafar |